Webinar: How Cancer Circumvents the Immune System
The immune system normally identifies and eliminates cancer cells prior to tumor formation. However, cancer cells can induce inhibitory mechanisms that limit antitumor immune activity, allowing for disease progression. In this webinar, Dario Vignali and Peter Westcott will discuss the tug-of-war between cancer cells and the immune system, how cancer cells evade immune cells, and what can be done to circumvent or attenuate these mechanisms for therapeutic purposes.
Topics to be covered
- Understanding immune inhibitory mechanisms in cancer
- Modeling T-cell dysfunction in colon cancer
Dario A. Vignali, PhD Frank Dixon Chair in Cancer Immunology Vice Chair and Distinguished Professor of Immunology Director, Cancer Immunology Training Program Department of Immunology, School of Medicine University of Pittsburgh
Peter Westcott, PhD Postdoctoral Scientist David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology